Bond Cliff

Main Menu

  • Home
  • Economic integration
  • Price index
  • Covariance
  • Labor augmenting
  • Fund

Bond Cliff

Header Banner

Bond Cliff

  • Home
  • Economic integration
  • Price index
  • Covariance
  • Labor augmenting
  • Fund
Covariance
Home›Covariance›Molecular imaging suggests long-lasting symptoms of COVID may be caused by fatigue, not regional brain dysfunction

Molecular imaging suggests long-lasting symptoms of COVID may be caused by fatigue, not regional brain dysfunction

By Susan Weiner
October 30, 2021
0
0


18F-FDG PET in patients with long-COVID syndrome. A and B: averaged transaxial sections of the group, spatially normalized 18F-FDG PET in patients with long-COVID syndrome (A) and control patients (B). C: The model expression score (PES; * adjusted for age and sex, for illustration purposes) of the previously established COVID-19 spatial covariance model was not significantly different between patients with COVID-19 long syndrome and control patients. Boxplots (gray), as well as individual values ​​for COVID-19 patients (red) and the control cohort (green), are displayed. Credit: Society for Nuclear Medicine and Molecular Imaging

Long-term cognitive problems after a diagnosis of COVID-19 may be the result of fatigue rather than pathological changes in the brain, according to a study published ahead of print in the Journal of Nuclear Medicine. Analysis of neuropsychological tests and 18F-FDG PET imaging showed that little or no objective impairment was observed in the cognition and brain pathology of long-term COVID patients; however, many of the group suffered from subjective complaints such as severe fatigue.

The term “long COVID syndrome” is used to describe symptoms that occur following infection with COVID-19 (generally defined as being present more than 12 weeks after infection), including cognitive deficits, such as brain fog, memory loss and attention problems, as well as fatigue and exhaustion. The underlying cause of these symptoms is unknown.

Previously published studies have shown that patients requiring hospital treatment due to a new diagnosis of COVID-19 reduced glucose metabolism in the brain, which is associated with impaired cognitive function. To assess whether patients with long COVID have similar deficits, the researchers performed neuropsychological tests and 18F-FDG PET brain imaging.

Thirty-one patients who sought counseling for persistent neurocognitive symptoms were included in the present study. Patients participated in a battery of neuropsychological tests, and the results were analyzed to determine levels of cognitive impairment. The average results of the testing group showed no impairment. Slight deficits have been observed in some patients at the single subject level, however, primarily with regard to visual memory.

18F-FDG PET imaging was recommended for all counseling patients, and 14 of 31 patients continued on treatment. Clinical evaluation of each patient’s examination revealed no distinct pathological signs or alternative diagnosis. When the scans were compared to those of a control group, no significant difference was noted.

The absence of significant results on 18F-FDG CT scans and only mild impairment on neuropsychological tests contrasts with the severe and lasting disability self-reported by patients. Fatigue, however, was particularly prevalent in the group, reported by 61 percent of study participants. Fatigue often follows viral infections and inflammation and has been linked to immune processes and chronic fatigue syndrome throughout COVID.

“This suggests that fatigue, no brain regional dysfunction, may be responsible for many long-lasting symptoms of COVID, ”the researchers concluded.


Recovering patients often experience long-term “brain fog”


More information:
Andrea Dressing et al, Neuropsychological Profiles and Brain Glucose Metabolism in Long COVID Neurocognitive Syndrome, Journal of Nuclear Medicine (2021). DOI: 10.2967 / jnumed.121.262677

Provided by
Society of Nuclear Medicine and Molecular Imaging

Quote:
Molecular Imaging Suggests Long-Lasting Symptoms of COVID May Be Caused by Fatigue, Not Regional Brain Dysfunction (2021, October 29)
retrieved October 30, 2021
from https://medicalxpress.com/news/2021-10-molecular-imaging-long-covid-symptoms-fatigue.html

This document is subject to copyright. Apart from any fair use for study or private research, no
part may be reproduced without written permission. The content is provided for information only.


Related posts:

  1. Counting of equilibria of large complex systems by instability index
  2. Testosterone, free, bioavailable and total, in patients with COVID-19
  3. Is patient participation in multidisciplinary tumor conferences associated with their information needs? A multicenter prospective observational study
  4. Bladder cancer and exercise training during intravesical therapy – the BRAVE trial: a study protocol for a phase II, prospective, single-center randomized controlled trial
Tagslong term

Categories

  • Covariance
  • Economic integration
  • Fund
  • Labor augmenting
  • Price index
  • TERMS AND CONDITIONS
  • Privacy Policy